Analysts Offer Insights on Technology Companies: PagerDuty (PD) and Renalytix AI (RNLX)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on PagerDuty (PD – Research Report) and Renalytix AI (RNLX – Research Report) with bullish sentiments.

PagerDuty (PD)

Berenberg Bank analyst Kingsley Crane maintained a Buy rating on PagerDuty yesterday and set a price target of $56.00. The company’s shares closed last Wednesday at $37.25.

According to TipRanks.com, Crane is a 2-star analyst with an average return of 3.5% and a 35.5% success rate. Crane covers the Technology sector, focusing on stocks such as SailPoint Technologies Holdings, CrowdStrike Holdings, and Datto Holding.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for PagerDuty with a $57.30 average price target, implying a 56.5% upside from current levels. In a report issued on November 30, Monness also maintained a Buy rating on the stock with a $66.00 price target.

See the top stocks recommended by analysts >>

Renalytix AI (RNLX)

In a report released yesterday, Anita Dushyanth from Berenberg Bank maintained a Buy rating on Renalytix AI, with a price target of $35.00. The company’s shares closed last Wednesday at $15.23, close to its 52-week low of $11.85.

According to TipRanks.com, Dushyanth has 0 stars on 0-5 stars ranking scale with an average return of -23.8% and a 5.9% success rate. Dushyanth covers the Healthcare sector, focusing on stocks such as Bioxcel Therapeutics, Kodiak Sciences, and Halozyme.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Renalytix AI with a $30.33 average price target, representing a 92.2% upside. In a report issued on December 7, Stifel Nicolaus also maintained a Buy rating on the stock with a $28.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PD:

• J.P. Morgan Thinks Prosus’ Stock is Going to Recover
• Analysts Offer Insights on Materials Companies: Olin (OLN) and JELD-WEN (JELD)
• Analysts Offer Insights on Consumer Goods Companies: Dollar General (DG) and Academy Sports and Outdoors (ASO)
• Leerink Partners Thinks Bolt Biotherapeutics’ Stock is Going to Recover
• Leerink Partners Thinks Aligos Therapeutics’ Stock is Going to Recover